Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis

R Baral, V Tsampasian, M Debski, B Moran… - JAMA network …, 2021 - jamanetwork.com
Importance The chronic receipt of angiotensin-converting enzyme inhibitors (ACEIs) and
angiotensin receptor blockers (ARBs) has been assumed to exacerbate complications …

[HTML][HTML] Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis

S Schlesinger, M Neuenschwander, A Lang, K Pafili… - Diabetologia, 2021 - Springer
Methods This is the first edition of a living systematic review and meta-analysis on
observational studies investigating phenotypes in individuals with diabetes and COVID-19 …

Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies

C Bavishi, PK Whelton, G Mancia, G Corrao… - Journal of …, 2021 - journals.lww.com
Aims: We sought to evaluate the association of angiotensin-converting-enzyme inhibitors
(ACEI) or AT1 blockers (ARB) therapy with clinical outcomes in patients with coronavirus …

Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis

S Schlesinger, A Lang, N Christodoulou, P Linnerz… - Diabetologia, 2023 - Springer
Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Renin‐angiotensin aldosterone system inhibitors and COVID‐19: a systematic review and meta‐analysis revealing critical bias across a body of observational …

J Loader, FC Taylor, E Lampa… - Journal of the American …, 2022 - Am Heart Assoc
Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies,
observational in design, appear to use biased methods that can distort the interaction …

Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis

SS Hasan, CS Kow, MA Hadi, STR Zaidi… - American Journal of …, 2020 - Springer
Introduction The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was …

Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade …

C Chu, S Zeng, AA Hasan, CF Hocher… - British Journal of …, 2021 - Wiley Online Library
Aims Angiotensin‐converting enzyme‐2 (ACE2) is the receptor for SARS‐CoV‐2. Animal
studies suggest that renin–angiotensin–aldosterone system (RAAS) blockers might increase …

Effects of renin‐angiotensin‐aldosterone system inhibitors on disease severity and mortality in patients with COVID‐19: A meta‐analysis

G Zhang, Y Wu, R Xu, X Du - Journal of medical virology, 2021 - Wiley Online Library
To investigate the effects of renin‐angiotensin‐aldosterone system (RAAS) inhibitors on the
prognosis in patients with coronavirus disease 2019 (COVID‐19). A meta‐analysis was …

[HTML][HTML] Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors in COVID-19: meta-analysis/meta-regression adjusted for confounding factors

T Lee, A Cau, MP Cheng, A Levin, TC Lee, DC Vinh… - CJC open, 2021 - Elsevier
Abstract Background Angiotensin receptor blockers (ARBs) and/or angiotensin-converting
enzyme (ACE) inhibitors could alter mortality from coronavirus disease 2019 (COVID-19) …

Controversial roles of the renin angiotensin system and its modulators during the COVID-19 pandemic

SB Gressens, G Leftheriotis, JC Dussaule… - Frontiers in …, 2021 - frontiersin.org
Since December 2019, the coronavirus 2019 (COVID-19) pandemic has rapidly spread and
overwhelmed healthcare systems worldwide, urging physicians to understand how to …